These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8216559)

  • 41. Luminol-dependent chemiluminescence in bovine eosinophils and neutrophils: differential increase of intracellular and extracellular chemiluminescence induced by soluble stimulants.
    Freiburghaus J; Jörg A; Müller T
    J Biolumin Chemilumin; 1991; 6(2):115-21. PubMed ID: 1882704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of long-term treatment with platelet-activating factor on cytokine production by rat spleen cells.
    Pignol B; Hénane S; Mencia-Huerta JM; Braquet P
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):161-3. PubMed ID: 2785086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherence of human monocytes to haemodialysis membranes: LFA 1 (CD11a/CD18) CR1 (CD35) and CR3 (CD11b/CD18) triggering promotes the biosynthesis of platelet-activating factor and adherence.
    Tetta C; Tropea F; Camussi G; Neri R; Wratten ML; Sereni L; Silvestro L; Franceschi C; Haeffner-Cavaillon N
    Nephrol Dial Transplant; 1995; 10(9):1679-88. PubMed ID: 8559489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors.
    Fujiu T; Kato M; Kimura H; Tachibana A; Suzuki M; Nako Y; Morikawa A
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):90-8. PubMed ID: 12141728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils.
    Moqbel R; Walsh GM; Nagakura T; MacDonald AJ; Wardlaw AJ; Iikura Y; Kay AB
    Immunology; 1990 Jun; 70(2):251-7. PubMed ID: 2373521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG; Chao W; Levine BA; Olson MS
    Am J Pathol; 1990 Dec; 137(6):1501-8. PubMed ID: 1701964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.
    Tomioka K; MacGlashan DW; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1993 Nov; 151(9):4989-97. PubMed ID: 8409452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The C3 activating capacity in human serum--measured as monocyte mediated chemiluminescence].
    Ernst M; Ennen J; Flad HD
    Immun Infekt; 1984 Feb; 12(1):35-6. PubMed ID: 6241919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation by IL-5 of expression of functional platelet-activating factor receptors on human eosinophils.
    Kishimoto S; Shimadzu W; Izumi T; Shimizu T; Fukuda T; Makino S; Sugiura T; Waku K
    J Immunol; 1996 Nov; 157(9):4126-32. PubMed ID: 8892648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitization primes platelet-activating factor (PAF)-induced accumulation of eosinophils in mouse skin lesions: contribution of cytokines to the response.
    Yukawa T; Terashi K; Terashi Y; Arima M; Sagara H; Motojima S; Fukuda T; Makino S
    J Lipid Mediat; 1992; 5(2):121-6. PubMed ID: 1525351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway.
    Urasaki T; Takasaki J; Nagasawa T; Ninomiya H
    J Leukoc Biol; 2001 Jan; 69(1):105-12. PubMed ID: 11200053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
    Gill P; Jindal NL; Jagdis A; Vadas P
    J Allergy Clin Immunol; 2015 Jun; 135(6):1424-32. PubMed ID: 26051949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin, and VLA-4 on human eosinophils and neutrophils.
    Neeley SP; Hamann KJ; White SR; Baranowski SL; Burch RA; Leff AR
    Am J Respir Cell Mol Biol; 1993 Jun; 8(6):633-9. PubMed ID: 7686761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
    Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
    Liu BJ; Zhang HT; Zheng MR
    Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
    Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P
    Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet activating factor antagonists interact with GABAA receptors.
    Miller LG; Bazan NG; Roy RB; Clostre F; Gaver A; Braquet P
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):253-6. PubMed ID: 1667341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.